Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeho
Many biopharma companies are investing in cell and gene therapy, albeit cautiously, amid a nascent market. Here are investment opportunities and entry strategies.
Nature Portfolio presents this Collection to celebrate the 2024 Nobel Prize in Physiology or Medicine, awarded jointly to Victor Ambros and Gary Ruvkun "for the discovery of microRNA and its role in post-transcriptional gene regulation". Innovations in Stem Cell Biology ...
英文题目:Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer 中文题目:基因组分析确定导管原位癌和复发浸润性乳腺癌的克隆关系 发表日期:2022-06-09 发表杂志:Nature genetics 影响因子:41.307
see what your cells are doing and when they do it. The Incucyte® SX1 instrument, proprietary assays and reagents provide you with the ability to gain new insights into biological processes via real-time, quantitative analysis of live cells. Conventional approaches to cell analysis only ca...
近日,云南中医药大学基础医学院科研中心实验室秦冬冬研究员团队在Frontiers in Cell and Developmental Biology上在线发表了题为“New Insights into the Interplay Between Autophagy and Cartilage Degeneration in Osteoarthritis”的综述。该文章第一作者为云南中医药大学科技处副处长吕小满副教授,共同第一作者为博士研究生...
影响因子:6.551 技术手段:miRNA芯片 Apple SERRATE negatively mediates drought resistance by regulating MdMYB88 and MdMYB124 and microRNA biogenesis 苹果中SERRATE通过调节MdMYB88和MdMYB124以及microRNA的生物发生来负调控抗旱性况 发表单位:西北农林大学 ...
Over recent years, the field of cell and gene therapy has witnessed rapid growth due to the demonstrated benefits of using living cells as therapeutic agents in a broad range of clinical studies and trials. Bioprocess economic models (BEMs) are fundamental tools for guiding decision-making in bio...
The analysis of complex cancer tissues at the single-cell level through scRNA-seq has brought insights into the heterogeneity and progression of cancer, as well as escape from immune surveillance, drug resistance, and intercellular communication [14]. However, scRNA-seq technology is expensive, ...
cell and gene therapy. Some topics of interest include pluripotent states, adult tissue stem cells, regeneration, wound healing, fibrosis, adult-, iPSC-, and tumor-organoids, applied biomaterials, organ-on-chip, tissue bioprinting, clinical and translational insights in cell and gene therapy, ...